5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione

C11H18N2O3 — CID 103140373

IUPAC5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione
SMILESCC1CCC(CN2C(=O)NC(=O)C2(C)C)O1
InChIInChI=1S/C11H18N2O3/c1-7-4-5-8(16-7)6-13-10(15)12-9(14)11(13,2)3/h7-8H,4-6H2,1-3H3,(H,12,14,15)
InChIKeyASAYIMWLAKAXCM-UHFFFAOYSA-N
MW226.28 g/mol
LogP0.88
Rot. Bonds2

About 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione

5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione (PubChem CID 103140373) has the molecular formula C11H18N2O3 and a molecular weight of 226.28 g/mol. Its IUPAC name is 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione.

Molecular Properties

Compound Name5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione
PubChem CID103140373
Molecular FormulaC11H18N2O3
Molecular Weight226.28 g/mol
Exact Mass226.13
IUPAC Name5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione
SMILESCC1CCC(CN2C(=O)NC(=O)C2(C)C)O1
InChIInChI=1S/C11H18N2O3/c1-7-4-5-8(16-7)6-13-10(15)12-9(14)11(13,2)3/h7-8H,4-6H2,1-3H3,(H,12,14,15)
InChIKeyASAYIMWLAKAXCM-UHFFFAOYSA-N
XLogP0.88
TPSA58.64 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds2
Heavy Atoms16
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500226.28
LogP ≤ 50.88
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3,3,6,6-tetramethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
CID 103141794
6-cyclopropyl-6-methyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
CID 103141996
5,5-dimethyl-1-(oxiran-2-ylmethyl)imidazolidine-2,4-dione;propan-2-ol
CID 158725431
5,5-dimethyl-1-(1-oxaspiro[4.5]decan-2-ylmethyl)imidazolidine-2,4-dione
CID 102901153
6-cyclopropyl-3,3-dimethyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
CID 103141791
3-methyl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,6-dione
CID 103137992
3-bromo-2,2-dimethyl-1-[(5-methyloxolan-2-yl)methyl]pyrrolidine
CID 130977992
3-ethyl-3,7-dimethyl-1-[(5-methyloxolan-2-yl)methyl]-1,4-diazepane-2,5-dione
CID 103142054
5,5-dimethyl-1-[(5-methyl-2,3-dihydro-1-benzofuran-2-yl)methyl]imidazolidine-2,4-dione
CID 66391954
3-butan-2-yl-1-[(5-methyloxolan-2-yl)methyl]piperazine-2,5-dione
CID 103142001
7-methyl-1-[(5-methyloxolan-2-yl)methyl]-3-propan-2-yl-1,4-diazepane-2,5-dione
CID 103142016
4-[(5-methyloxolan-2-yl)methyl]-1,4-diazaspiro[5.5]undecane-2,5-dione
CID 103142003

Frequently Asked Questions

What is the IUPAC name of 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione?
The IUPAC name of 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione (CID 103140373) is 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione.
What is the SMILES notation for 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione?
The canonical SMILES for 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione is CC1CCC(CN2C(=O)NC(=O)C2(C)C)O1.
What is the InChIKey of 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione?
The InChIKey is ASAYIMWLAKAXCM-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H18N2O3/c1-7-4-5-8(16-7)6-13-10(15)12-9(14)11(13,2)3/h7-8H,4-6H2,1-3H3,(H,12,14,15).
What are the key properties of 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione?
5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione has a molecular weight of 226.28 g/mol, XLogP of 0.88, 2 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 5,5-dimethyl-1-[(5-methyloxolan-2-yl)methyl]imidazolidine-2,4-dione is sourced from PubChem (CID 103140373), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).